View all cases
ORD 22248/2025
—
- Case details
- Status—ActionProcedural applicationCategoryCase Management Orders
- Parties
- Claimants
- Sanofi SA
- Sanofi Winthrop Industrie
- Sanofi-Aventis GmbH
- Sanofi Belgium
- Sanofi-Aventis Deutschland GmbH
- Sanofi S.r.l.
- Sanofi B.V.
- Sanofi - Produtos Farmaceuticos Lda
- Sanofi AB
- Sanofi A/S
Reps: Frédéric Chevallier (McDermott Will & Schulte)Respondents- Accord Healthcare S.L.U.
- Accord Healthcare GmbH (AT)
- Accord Healthcare B.V.
- Accord Healthcare GmbH (DE)
- Accord Healthcare Italia Srl
- Accord Healthcare, Unipessoal Lda.
- Accord Healthcare AB
- STADAPHARM GmbH
- STADA Arzneimittel AG
- STADA Nordic ApS
- Reddy Pharma SAS
- betapharm Arzneimittel GmbH
- Dr Reddy's Srl
- Zentiva France
- Zentiva Pharma GmbH
- Zentiva, k.s.
Reps: Jules Fabre (Taylor Wessing); Daniel Hoppe (Bonabry); Christian Meyer (Maiwald) - Division
- Munich LD
- Judges
- —
- Language
- —
- First decided
- Jul 17, 2025
Decisions
- 2025-07-17Generic Order
The Munich Local Division issued a procedural order in the consolidated Sanofi pharmaceutical patent cases against multiple generics manufacturers (Accord, STADA, Dr. Reddy's, Zentiva), addressing scheduling and management of the parallel infringement proceedings.
Legal issues:Procedural management of parallel pharmaceutical patent cases
Documents
- 2920CDB9F714C912ABE5BC84F9B8CFBB_en.pdf2025-07-17EN